Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02627092 · ClinicalTrials.gov registry record · NA
IMPACT STUDY: Investigating Microbial Pathogen Activity of Copper Textiles
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 585
- Enrollment target
NCT02627092: Completed NA study, sponsored by University of Pennsylvania.
NCT02627092 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 585 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02627092, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 585 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of copper linens on hospital acquired infections and drug resistant bacteria.
Interventions
- OTHER Copper linen exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2016-01 |
| Est. Completion | 2023-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02627092
The ClinicalTrials.gov registry entry for NCT02627092 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 585 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Copper linen exposure is the first listed.
NCT02627092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02627092 about?
NCT02627092 is a clinical study titled "IMPACT STUDY: Investigating Microbial Pathogen Activity of Copper Textiles". The purpose of this study is to assess the impact of copper linens on hospital acquired infections and drug resistant bacteria.
What is the current status of trial NCT02627092?
This trial is currently completed. It is a NA study. The enrollment target is 585 participants. The study started on 2016-01. Estimated completion is 2023-12.
What interventions are being tested in trial NCT02627092?
The interventions under investigation include: Copper linen exposure (OTHER).
Who is sponsoring clinical trial NCT02627092?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.